Moderna’s Announcement Was Great News - Just Not For The Reason You Think Moderna, a Boston-based ex-unicorn that has successfully developed and marketed as many drugs as you have, turned itself from a $6 billion midcap stock to a $27 billion large cap stock over the space of a few months and a handful of press releases.